Trial ID: | L0484 |
Source ID: | NCT03783195
|
Associated Drug: |
Fructose
|
Title: |
Genetic-specific Effects of Fructose on Liver Lipogenesis
|
Acronym: |
--
|
Status: |
Recruiting
|
Study Results: |
No Results Available
|
Results: |
--
|
Conditions: |
NAFLD;Non-Alcoholic Fatty Liver Disease
|
Interventions: |
Other: Sugar drink
|
Outcome Measures: |
Percent change in liver fat content from baseline to week 3;Percent change from baseline in very low density lipoprotein-triglycerides (VLDL-TG) production rate.Percent change from baseline to week 3 in serum concentrations of triglycerides;Percent change from baseline to week 3 in serum concentrations of HDL cholesterol;Percent change from baseline to week 3 in serum concentrations of LDL cholesterol;percent change from baseline to week 3 in serum concentrations of total cholesterol;Percent change from baseline to week 3 in serum concentrations of uric acid;Percent change from baseline to week 3 in serum concentrations of liver function marker (Alanine transaminase- ALT).;Percent change from baseline to week 3 in serum concentrations of liver function marker (Aspartate transaminase-AST).;Percent change from baseline to week 3 in serum concentrations of liver function marker (Alkaline phosphatase-ALP);Percent change from baseline to week 3 in serum concentrations of liver function marker (Gamma glutamyl transpeptidase-GGT)
|
Sponsor/Collaborators: |
University of North Carolina, Chapel Hill
|
Gender: |
All
|
Age: |
12 Years40 Years
|
Phases: |
Not applicable
|
Enrollment: |
48
|
Study Type: |
Interventional
|
Study Designs: |
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Basic Science. Masking: None (Open Label).
|
Start Date: |
17/12/2018
|
Completion Date: |
--
|
Results First Posted: |
--
|
Last Update Posted: |
12 December 2020
|
Locations: |
United States
|
URL: |
https://clinicaltrials.gov/show/NCT03783195
|